Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2000
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362464A1 A synthetic peptide disturbing intracellular signaling
08/17/2000CA2362368A1 Method for altering undesirable immune responses to polypeptides
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360292A1 Immunogenic compositions for use as vaccines
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2360164A1 5-ht1f agonists
08/17/2000CA2359674A1 Chain-shortened polynucleotide and method for preparation thereof
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028137A2 Polymeric matrices and their uses in pharmaceutical compositions
08/16/2000EP1027895A2 Erysipelothrix rhusiopathiae antigens and vaccine compositions
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027373A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027066A1 Soluble mhc complexes and methods of use thereof
08/16/2000EP1027063A1 Mannose receptor bearing cell line and antigen composition
08/16/2000EP1027061A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
08/16/2000EP1027053A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
08/16/2000EP0812194B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103889 Nucleic acid molecules encoding single-chain antigen-binding proteins
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/15/2000US6103718 Selective cyclic nucleotide phosphodiesterase (pde) inhibitors (specifically of type 4) which are effective bronchial therapeutics; bronchodilators; respiratory system disorders
08/15/2000US6103713 Therapeutic treatment for autoimmune diseases
08/15/2000US6103711 Inhibitors of interleukin-1β converting enzyme
08/15/2000US6103710 Glucocorticoid response elements
08/15/2000US6103697 Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response
08/15/2000US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site
08/15/2000US6103243 Oral vaccines
08/15/2000US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000CA2153391C Inducing cytotoxic t lymphocyte responses
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/15/2000CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same
08/15/2000CA2136553C 7-(2-aminoethyl)-benzothiazolones
08/15/2000CA2046883C Heterocyclic derivatives, method for preparing same, and their therapeutic applications
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046390A1 T helper cell epitopes
08/10/2000WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000WO2000046350A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals
08/10/2000WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045847A1 Novel mucosal delivery system
08/10/2000WO2000045843A1 Novel sialoadhesins
08/10/2000WO2000045842A2 Methods for human allografting
08/10/2000WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045834A2 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
08/10/2000WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/10/2000WO2000045827A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
08/10/2000WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045800A2 Immunosurpressive effects of pteridine derivatives
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000025810A3 Immunomodulatory factors for immunosuppressant and antiallergic treatment
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19905048A1 Verwendung depletorisch oder mitogen wirkender Antikörper in der Immuntherapie Use depletorisch or mitogen-acting antibodies in immunotherapy
08/10/2000DE19905012A1 Arzneimittel enthaltend Anti-CD3- und Anti-Fcgamma-R-Antikörper zur begleitenden Behandlung bei Organtransplantationen Medicines containing anti-CD3 and anti-Fcgamma-R antibody for concomitant therapy in organ transplantation
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361658A1 T helper cell epitopes
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361561A1 Immunosurpressive effects of pteridine derivatives
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361539A1 Compressed lecithin preparations
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2360670A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2321107A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026167A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
08/09/2000EP1026147A1 Compounds useful as intermediates in the production of piperidine derivatives
1 ... 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 ... 1172